C07C 311/37
Having the sulfur atom of at least one of the sulfonamide groups
Official title: having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
C07C311/37 (Having the sulfur atom of at least one of the sulfonamide groups) appears on 617 US grants and 566 published applications in this corpus.
Search patents in C07C- Granted patents
- 617
- Published applications
- 566
- Assignees
- 390
- Inventors
- 2,111
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 5 | 0 |
| 1978 | 10 | 0 |
| 1979 | 3 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 8 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 13 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 19 | 0 |
| 1999 | 19 | 0 |
| 2000 | 21 | 0 |
| 2001 | 21 | 2 |
| 2002 | 33 | 27 |
| 2003 | 27 | 40 |
| 2004 | 20 | 43 |
| 2005 | 25 | 35 |
| 2006 | 20 | 30 |
| 2007 | 23 | 29 |
| 2008 | 18 | 25 |
| 2009 | 23 | 24 |
| 2010 | 11 | 31 |
| 2011 | 20 | 16 |
| 2012 | 23 | 23 |
| 2013 | 19 | 23 |
| 2014 | 23 | 29 |
| 2015 | 17 | 33 |
| 2016 | 12 | 18 |
| 2017 | 19 | 19 |
| 2018 | 14 | 16 |
| 2019 | 14 | 18 |
| 2020 | 15 | 11 |
| 2021 | 14 | 17 |
| 2022 | 11 | 18 |
| 2023 | 4 | 12 |
| 2024 | 11 | 13 |
| 2025 | 5 | 11 |
| 2026 | 8 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Methods of treating cancer21 Apr 2026US 12,606,521 B2Institute For Cancer Research
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Compounds and methods for treating cancer18 Jun 2026US 2026/0166051 A1The Regents of the University of California
- Bumetanide Derivatives for the Therapy of Stroke and Other Neurological Diseases/Disorders Involving NKCCs14 May 2026US 2026/0132103 A1The United States Government as represented by the Department of Veterans Affairs
- Phenylalanine-based lat1 inhibitors and uses thereof6 Nov 2025US 2025/0339388 A1Maxymune Therapeutics, Inc.
- Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof6 Nov 2025US 2025/0340510 A1Nine Square Therapeutics Corporation
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Modulators of ATP-binding cassette transporters105US 8,101,767 B2Vertex Pharmaceuticals Incorporated · 2012
- Aryl and heteroaryl compounds, compositions and methods of use99US 7,501,538 B2TransTech Pharma, Inc. · 2009